A Shortened Antiepileptic Drug (AED) Course in Surgical Brain Tumor Patients: A Randomized Trial

Trial Profile

A Shortened Antiepileptic Drug (AED) Course in Surgical Brain Tumor Patients: A Randomized Trial

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Apr 2017

At a glance

  • Drugs Levetiracetam (Primary)
  • Indications Seizures
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Aug 2015 Primary endpoint changed from seizure activity to difference in neurotoxicity scale scores, also patient number changed from 234 to 82, as reported by ClinicalTrials.gov.
    • 20 Aug 2015 Planned number of patients changed from 234 to 82, as reported by ClinicalTrials.gov.
    • 20 Aug 2015 Planned End Date changed from 1 Sep 2020 to 1 Oct 2017, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top